Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pyloriSUGIMOTO, Mitsushige; FURUTA, Takahisa; YAMAOKA, Yoshio et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 11, pp 1725-1732, issn 0815-9319, 8 p.Article

Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbilsSUGIMOTO, Mitsushige; OHNO, Tomoyuki; GRAHAM, David Y et al.Journal of gastroenterology and hepatology. 2011, Vol 26, Num 11, pp 1677-1684, issn 0815-9319, 8 p.Article

homB Status of Helicobacter pylori as a Novel Marker To Distinguish Gastric Cancer from Duodenal UlcerSUNG WOO JUNG; SUGIMOTO, Mitsushige; GRAHAM, David Y et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 10, pp 3241-3245, issn 0095-1137, 5 p.Article

Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbilsSUGIMOTO, Mitsushige; OHNO, Tomoyuki; GRAHAM, David Y et al.Cancer science. 2009, Vol 100, Num 11, pp 2152-2159, issn 1347-9032, 8 p.Article

Prevalence of Helicobacter pylori infection in long-term hemodialysis patientsSUGIMOTO, Mitsushige; SAKAI, Kyoko; KITA, Masakazu et al.Kidney international. 2009, Vol 75, Num 1, pp 96-103, issn 0085-2538, 8 p.Article

Inverse association between Helicobacter pylori infection and allergic rhinitis in young JapaneseIMAMURA, Shigeyoshi; SUGIMOTO, Mitsushige; KANEMASA, Kazuyuki et al.Journal of gastroenterology and hepatology. 2010, Vol 25, Num 7, pp 1244-1249, issn 0815-9319, 6 p.Article

Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype statusSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 5, pp 539-548, issn 0009-9236, 10 p.Article

Role of Helicobacter pylori Plasticity Region Genes in Development of Gastroduodenal DiseasesSUGIMOTO, Mitsushige; WATADA, Masahide; SUNG WOO JUNG et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 2, pp 441-448, issn 0095-1137, 8 p.Article

Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjectsSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 9, pp 1443-1449, issn 0815-9319, 7 p.Article

Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in JapanSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 10, pp 1929-1934, issn 1055-9965, 6 p.Article

Regression of primary gastric diffuse large B-cell lymphoma after eradication of Helicobacter pyloriSUGIMOTO, Mitsushige; KAJIMURA, Masayoshi; SATO, Yoshihiko et al.Gastrointestinal endoscopy. 2001, Vol 54, Num 5, pp 643-645, issn 0016-5107Article

Resistance of Helicobacter pylori to quinolones and clarithromvcin assessed bv genetic testing in JapanYAMADE, Mihoko; SUGIMOTO, Mitsushige; UOTANI, Takahiro et al.Journal of gastroenterology and hepatology. 2011, Vol 26, Num 9, pp 1457-1461, issn 0815-9319, 5 p.Article

Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction methodNAKAMURA, Akiko; FURUTA, Takahisa; SHIRAI, Naohito et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 7, pp 1057-1063, issn 0815-9319, 7 p.Article

Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycinFURUTA, Takahisa; SOYA, Yoshihiro; FUJIOKA, Toshio et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 11, pp 1810-1815, issn 0815-9319, 6 p.Article

Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in JapaneseSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 9, pp 2036-2040, issn 0143-3334, 5 p.Article

High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillinFURUTA, Takahisa; SHIRAI, Naohito; FANG XIAO et al.Hepato-gastroenterology. 2003, Vol 50, Num 54, pp 2274-2278, issn 0172-6390, 5 p.Article

Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjectsKODAIRA, Chise; SUGIMOTO, Mitsushige; FURUTA, Takahisa et al.European journal of clinical pharmacology. 2009, Vol 65, Num 6, pp 593-600, issn 0031-6970, 8 p.Article

Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype statusSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 4, pp 290-301, issn 0009-9236, 12 p.Article

Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy VolunteersNISHINO, Masafumi; SUGIMOTO, Mitsushige; KODAIRA, Chise et al.Digestive diseases and sciences. 2010, Vol 55, Num 6, pp 1627-1636, issn 0163-2116, 10 p.Article

CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazoleFURUTA, Takahisa; SUGIMOTO, Mitsushige; HISHIDA, Akira et al.European journal of clinical pharmacology. 2009, Vol 65, Num 7, pp 693-698, issn 0031-6970, 6 p.Article

Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populationsOHNO, Tomoyuki; SUGIMOTO, Mitsushige; NAGASHIMA, Aiko et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 3, pp 462-468, issn 0815-9319, 7 p.Article

Role of Deletion Located between the Intermediate and Middle Regions of the Helicobacter pylori vacA Gene in Cases of Gastroduodenal DiseasesOGIWARA, Hiroaki; SUGIMOTO, Mitsushige; OHNO, Tomoyuki et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 11, pp 3493-3500, issn 0095-1137, 8 p.Article

Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in JapaneseSUGIMOTO, Mitsushige; SHIRAI, Naohito; NISHINO, Masafumi et al.European journal of clinical pharmacology. 2014, Vol 70, Num 9, pp 1073-1078, issn 0031-6970, 6 p.Article

Trastuzumab Has Opposing Effects on SN-38-induced Double-strand Breaks and Cytotoxicity in HER2-positive Gastric Cancer Cells Depending on Administration SequenceYAMADE, Mihoko; SUGIMOTO, Mitsushige; FURUTA, Takahisa et al.Anticancer research. 2012, Vol 32, Num 1, pp 105-114, issn 0250-7005, 10 p., aArticle

Serum Pepsinogens as an Early Diagnostic Marker of H. pylori EradicationSHIRAI, Naohito; FURUTA, Takahisa; KODAIRA, Makoto et al.Hepato-gastroenterology. 2008, Vol 55, Num 82-83, pp 486-490, issn 0172-6390, 5 p.Article